Resolve Therapeutics Lands $2,000,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cb3d6987-f8f0-4dcb-9cf8-9a35785c8e87&Preview=1 - Date
5/17/2011 - Company Name
Resolve Therapeutics - Mailing Address
5400 Carillon Point Kirkland, WA 98033 - Company Description
Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy. - Website
http://www.resolvebio.com - Transaction Type
Venture Equity - Transaction Amount
$2,000,000 - Transaction Round
Series A - Proceeds Purposes
We continue to make progress towards our goal of clinical proof-of-concept for our investigational lupus compound RSLV-125. - M&A Terms
- Venture Investor
New Science Ventures - Venture Investor
Easton Capital
